Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hollander

Showing results (71-80 of 246) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|September 6, 2003
Targeted treatments for symptom domains in child and adolescent autismEric Hollander, Ann T Phillips, Chin-Chin Yeh
Pharmacology & Therapeutics|October 25, 2024
Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndromeAlyssa Josselsohn, Yin Zhao, Danielle Espinoza, et al.
The Journal of Clinical Psychiatry|May 4, 2006
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical reviewBernardo Dell'Osso, Gerald Nestadt, Andrea Allen, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Serotonin function in pathological gambling: blunted growth hormone response to sumatriptanStefano Pallanti, Silvia Bernardi, Andrea Allen, et al.
Expert Opinion on Pharmacotherapy|May 1, 2019
Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatmentsNancy Dong, Vera Nezgovorova, Kevin Hong, et al.
Journal of Clinical Psychopharmacology|September 16, 2016
Prevalence of Selective Serotonin Reuptake Inhibitor-Related Apathy in Patients With Obsessive Compulsive DisorderBernardo DellʼOsso, Beatrice Benatti, Alfredo Carlo Altamura, et al.
Journal of Psychiatric Research|November 23, 2021
Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorderVera Nezgovorova, Casara Jean Ferretti, Stefano Pallanti, et al.
International Journal of Psychiatry in Clinical Practice|November 5, 2016
Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorderBernardo Dell'Osso, Beatrice Benatti, Eric Hollander, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Nefazodone treatment of pathological gambling: a prospective open-label controlled trialStefano Pallanti, Nicolò Baldini Rossi, Erica Sood, et al.
Psychiatry Research|October 10, 2009
Neurological considerations: autism and Parkinson's diseaseEric Hollander, A Ting Wang, Ashley Braun, et al.
Pageof 25

Showing results (71-80 of 246) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|September 6, 2003
Targeted treatments for symptom domains in child and adolescent autismEric Hollander, Ann T Phillips, Chin-Chin Yeh
Pharmacology & Therapeutics|October 25, 2024
Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndromeAlyssa Josselsohn, Yin Zhao, Danielle Espinoza, et al.
The Journal of Clinical Psychiatry|May 4, 2006
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical reviewBernardo Dell'Osso, Gerald Nestadt, Andrea Allen, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Serotonin function in pathological gambling: blunted growth hormone response to sumatriptanStefano Pallanti, Silvia Bernardi, Andrea Allen, et al.
Expert Opinion on Pharmacotherapy|May 1, 2019
Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatmentsNancy Dong, Vera Nezgovorova, Kevin Hong, et al.
Journal of Clinical Psychopharmacology|September 16, 2016
Prevalence of Selective Serotonin Reuptake Inhibitor-Related Apathy in Patients With Obsessive Compulsive DisorderBernardo DellʼOsso, Beatrice Benatti, Alfredo Carlo Altamura, et al.
Journal of Psychiatric Research|November 23, 2021
Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorderVera Nezgovorova, Casara Jean Ferretti, Stefano Pallanti, et al.
International Journal of Psychiatry in Clinical Practice|November 5, 2016
Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorderBernardo Dell'Osso, Beatrice Benatti, Eric Hollander, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Nefazodone treatment of pathological gambling: a prospective open-label controlled trialStefano Pallanti, Nicolò Baldini Rossi, Erica Sood, et al.
Psychiatry Research|October 10, 2009
Neurological considerations: autism and Parkinson's diseaseEric Hollander, A Ting Wang, Ashley Braun, et al.
Pageof 25